Remove pharma fda-investigates-serious-risk-secondary-cancer-following-car-t-therapy-treatment
article thumbnail

COVID-19 Pandemic Coverage

XTalks

These responses provided complete or near-complete protection in bronchoalveolar lavage and nasal swabs following SARS-CoV-2 challenge, suggesting that a single shot of the J&J candidate vaccine protected at least nonhuman primates against SARS-CoV-2 infection. New COVID-19 Treatments. Update: July 27, 2020.